Literature DB >> 30382943

Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer.

Daniel Nava Rodrigues, Pasquale Rescigno, David Liu, Wei Yuan, Suzanne Carreira, Maryou B Lambros, George Seed, Joaquin Mateo, Ruth Riisnaes, Stephanie Mullane, Claire Margolis, Diana Miao, Susana Miranda, David Dolling, Matthew Clarke, Claudia Bertan, Mateus Crespo, Gunther Boysen, Ana Ferreira, Adam Sharp, Ines Figueiredo, Daniel Keliher, Saud Aldubayan, Kelly P Burke, Semini Sumanasuriya, Mariane Sousa Fontes, Diletta Bianchini, Zafeiris Zafeiriou, Larissa Sena Teixeira Mendes, Kent Mouw, Michael T Schweizer, Colin C Pritchard, Stephen Salipante, Mary-Ellen Taplin, Himisha Beltran, Mark A Rubin, Marcin Cieslik, Dan Robinson, Elizabeth Heath, Nikolaus Schultz, Joshua Armenia, Wassim Abida, Howard Scher, Christopher Lord, Alan D'Andrea, Charles L Sawyers, Arul M Chinnaiyan, Andrea Alimonti, Peter S Nelson, Charles G Drake, Eliezer M Van Allen, Johann S de Bono.   

Abstract

Entities:  

Year:  2018        PMID： 30382943      PMCID： PMC6205373          DOI： 10.1172/JCI125184

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  24 in total

Review 1.  Clinical implications of mismatch repair deficiency in prostate cancer.

Authors:  Ramy Sedhom; Emmanuel S Antonarakis
Journal:  Future Oncol       Date:  2019-06-25       Impact factor: 3.404

2.  Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study.

Authors:  Emmanuel S Antonarakis; Josep M Piulats; Marine Gross-Goupil; Jeffrey Goh; Kristiina Ojamaa; Christopher J Hoimes; Ulka Vaishampayan; Ranaan Berger; Ahmet Sezer; Tuomo Alanko; Ronald de Wit; Chunde Li; Aurelius Omlin; Giuseppe Procopio; Satoshi Fukasawa; Ken-Ichi Tabata; Se Hoon Park; Susan Feyerabend; Charles G Drake; Haiyan Wu; Ping Qiu; Jeri Kim; Christian Poehlein; Johann Sebastian de Bono
Journal:  J Clin Oncol       Date:  2019-11-27       Impact factor: 44.544

3.  Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer.

Authors:  Theodore S Hong; Eliezer M Van Allen; Sophia C Kamran; Jochen K Lennerz; Claire A Margolis; David Liu; Brendan Reardon; Stephanie A Wankowicz; Emily E Van Seventer; Adam Tracy; Jennifer Y Wo; Scott L Carter; Henning Willers; Ryan B Corcoran
Journal:  Clin Cancer Res       Date:  2019-06-28       Impact factor: 12.531

4.  Associations among the mutational landscape, immune microenvironment, and prognosis in Chinese patients with hepatocellular carcinoma.

Authors:  Zhi-Qiang Hu; Hao-Yang Xin; Chu-Bin Luo; Jia Li; Zheng-Jun Zhou; Ji-Xue Zou; Shao-Lai Zhou
Journal:  Cancer Immunol Immunother       Date:  2020-08-06       Impact factor: 6.968

5.  Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.

Authors:  Panagiotis A Konstantinopoulos; Barbara Norquist; Christina Lacchetti; Deborah Armstrong; Rachel N Grisham; Paul J Goodfellow; Elise C Kohn; Douglas A Levine; Joyce F Liu; Karen H Lu; Dorinda Sparacio; Christina M Annunziata
Journal:  J Clin Oncol       Date:  2020-01-27       Impact factor: 44.544

6.  EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer.

Authors:  Katherine L Morel; Anjali V Sheahan; Deborah L Burkhart; Sylvan C Baca; Nadia Boufaied; Yin Liu; Xintao Qiu; Israel Cañadas; Kevin Roehle; Max Heckler; Carla Calagua; Huihui Ye; Constantia Pantelidou; Phillip Galbo; Sukanya Panja; Antonina Mitrofanova; Scott Wilkinson; Nichelle C Whitlock; Shana Y Trostel; Anis A Hamid; Adam S Kibel; David A Barbie; Atish D Choudhury; Mark M Pomerantz; Christopher J Sweeney; Henry W Long; David J Einstein; Geoffrey I Shapiro; Stephanie K Dougan; Adam G Sowalsky; Housheng Hansen He; Matthew L Freedman; Steven P Balk; Massimo Loda; David P Labbé; Brian M Olson; Leigh Ellis
Journal:  Nat Cancer       Date:  2021-03-22

7.  Hypermutation, Mismatch Repair Deficiency, and Defining Predictors of Response to Checkpoint Blockade.

Authors:  Laura S Graham; Colin C Pritchard; Michael T Schweizer
Journal:  Clin Cancer Res       Date:  2021-09-27       Impact factor: 13.801

Review 8.  Prostate carcinogenesis: inflammatory storms.

Authors:  Johann S de Bono; Christina Guo; Bora Gurel; Angelo M De Marzo; Karen S Sfanos; Ram S Mani; Jesús Gil; Charles G Drake; Andrea Alimonti
Journal:  Nat Rev Cancer       Date:  2020-06-16       Impact factor: 60.716

Review 9.  Prostate Cancer Immunotherapy-Finally in From the Cold?

Authors:  Karie D Runcie; Matthew C Dallos
Journal:  Curr Oncol Rep       Date:  2021-06-14       Impact factor: 5.075

10.  CD38 in Advanced Prostate Cancers.

Authors:  Christina Guo; Mateus Crespo; Bora Gurel; David Dolling; Jan Rekowski; Adam Sharp; Antonella Petremolo; Semini Sumanasuriya; Daniel N Rodrigues; Ana Ferreira; Rita Pereira; Ines Figueiredo; Niven Mehra; Maryou B K Lambros; Antje Neeb; Veronica Gil; George Seed; Leon Terstappen; Andrea Alimonti; Charles G Drake; Wei Yuan; Johann S de Bono
Journal:  Eur Urol       Date:  2021-03-05       Impact factor: 20.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.